课题基金 / 基金详情

Artificial Extracellular Matrix Proteins

Artificial Extracellular Matrix Proteins
人工细胞外基质蛋白
批准号:
9901648
负责人:
David Tirrell
金额:
$32.96万
依托单位国家:
美国
项目类别:
Continuing Grant
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-01 至 2003-02-28

项目摘要

项目成果

David Tirrell的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The objective of this project is to design and synthesize a new class of protein biomaterials for use in vascular graft applications. The proteins consist of repeats of elastin derived polypeptides with various cell binding peptides. They will be produced by expressing artificial genes in bacteria. The molecular structure of the materials will be manipulated via peptide sequence modifications and crosslinking methods in order to optimize mechanical and cell interaction properties. Finally, the attachment, spreading and function of vascular endothelial and smooth muscle cells on these materials will be evaluated under both static and perfused culture conditions, as a function of molecular properties.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
From Genes to Gels: Programming the Physical Properties of Artificial Protein Hydrogels
  • 批准号:
    1506483
  • 项目类别:
    Standard Grant
  • 资助金额:
    $63.26万
  • 财政年份:
    2015
  • 负责人:
    David Tirrell
  • 依托单位:
From Genes to Gels: Programming the Physical and Biological Properties of Multifunctional Protein Hydrogels
  • 批准号:
    1206121
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $45.0万
  • 财政年份:
    2012
  • 负责人:
    David Tirrell
  • 依托单位:
Important Areas for Future Biomaterials Investments
  • 批准号:
    1237457
  • 项目类别:
    Standard Grant
  • 资助金额:
    $16.5万
  • 财政年份:
    2012
  • 负责人:
    David Tirrell
  • 依托单位:
CRIF:MU Purchase of an X-ray Diffractometer for Research and Education
  • 批准号:
    0639094
  • 项目类别:
    Standard Grant
  • 资助金额:
    $34.05万
  • 财政年份:
    2007
  • 负责人:
    David Tirrell
  • 依托单位:
国内基金
海外基金
Mettl3/Syk/MAPK通路调控中性粒细胞胞 外诱捕网 (neutrophil extracellular traps, NETs)的形成对脓毒症急性肺损 伤影响的分子机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    罗舒华
  • 依托单位: